Page results
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
-
Prosthodontics is the reconstruction and replacement of teeth damaged as a result of congenital disorders and traumatic injuries; and includes the rehabilitation of patients with tissue lost as a result of injury.
-
The oral and maxillofacial surgery department focuses on the delivery of care to patients with dento-alveolar needs.
-
Oral medicine is the non-surgical management of patients with diseases of the oral mucosal tissues (lining of the mouth).
-
This page explains what a cervical cerclage involves and the risks and benefits of the procedure.
-
Our pain clinics are patient-centred and evidence-based, encouraging patients to self-manage their persistent facial pain.
-
First Seizure Clinic patient information leaflet
File results
-
FOI/2022/0360 - Staff contact details in charge of catering, vending and beverages
-
FOI/2022/0364 - Onsite incinerator
-
FOI/2022/0365 - Job roles at Trust with net zero in title
-
FOI/2022/0367 - Coagulation testing
-
FOI/2022/0368 - Recruitment data
-
FOI/2022/0369 - Inpatient mental health facilities
-
FOI/2022/0371 - Patients presented at A&E with dental health problems
-
FOI/2022/0372 - Number of offences relating to sexual misconduct
-
FOI/2022/0373 - Policy for patients with orthopaedic injuries sustained whilst staying away from home
-
FOI/2022/0377 - Usage of Dabrafenib + Trametinib in cancer treatment